Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Cardiovascular Toxicology
Published in: Cardiovascular Toxicology 4/2024

11-03-2024 | Nutrition | Research

Association Between Cancer and Cardiovascular Toxicity: A Nationwide Cross-Sectional Study on NHANES 1999–2018

Authors: Ruihuan Shen, Tong Zou

Published in: Cardiovascular Toxicology | Issue 4/2024

Login to get access

Abstract

There is a dearth of evidence pertaining to the relationship of cardiovascular disease (CVD) and its subtype with adjudicated cancer, thereby limiting our understanding of the heightened risk of CVD resulting from long-term complications of cancer and its therapies. The aim of this study was to quantify the risks of CVD and its subtypes in adult cancer survivors compared with cancer-free controls in a nationwide cross-sectional study on Continuous National Health and Nutrition Examination Survey (NHANES). We included 44,442 participants ranging in age from 20 to 85 years. Cancer and CVD diagnoses were ascertained via the household questionnaires. The association of cancer status with the risk of CVD and CVD subtype was examined using weighted logistic regression. Stratification analyses were also performed by age, sex, race, marital status, income status, educational level, and hyperlipidemia. The Wald test was used to calculate P-value for interaction. A total of 4178 participants have cancer, while 4829 participants had CVD, respectively. In the multivariable-adjusted model, the cancer was consistently linked to an elevated risk of CVD. Stratification analyses showed that stronger association between cancer status and CVD risk was found in younger adults, non-white, and participants living without a spouse or partner, and without hyperlipidemia. Our study confirmed that cancer participants were strongly linked to living with CVD, independent of traditional cardiovascular risk factors, especially in younger adults, non-white, and participants living without a spouse or partner, and without hyperlipidemia. There exists a pressing requirement to establish effective strategies for the prevention of CVD within this population characterized by a heightened risk.
Appendix
Available only for authorised users
Literature
1.
Stoltzfus, K. C., Zhang, Y., Sturgeon, K., Sinoway, L. I., Trifiletti, D. M., Chinchilli, V. M., & Zaorsky, N. G. (2020). Fatal heart disease among cancer patients. Nature Communications, 11(1), 2011.PubMedPubMedCentralCrossRef
2.
Sturgeon, K. M., Deng, L., Bluethmann, S. M., Zhou, S., Trifiletti, D. M., Jiang, C., Kelly, S. P., & Zaorsky, N. G. (2019). A population-based study of cardiovascular disease mortality risk in US cancer patients. European Heart Journal, 40(48), 3889–3897.PubMedPubMedCentralCrossRef
3.
Miller, K. D., Nogueira, L., Mariotto, A. B., Rowland, J. H., Robin Yabroff, K., Alfano, C. M., Jemal, A., Kramer, J. L., & Siegel, R. L. (2019). Cancer treatment and survivorship statistics. CA: A Cancer Journal for Clinicians, 69(5), 363–385.PubMed
4.
Karlstaedt, A., Moslehi, J., & de Boer, R. A. (2022). Cardio-onco-metabolism: Metabolic remodelling in cardiovascular disease and cancer. Nature Reviews Cardiology, 19(6), 414–425.PubMedPubMedCentralCrossRef
5.
Sener, U., & Keser, Z. (2022). Ischemic stroke in patients with malignancy. Mayo Clinic Proceedings, 97(11), 2139–2144.PubMedCrossRef
6.
Hahn, V. S., Zhang, K. W., Sun, L., Narayan, V., Lenihan, D. J., & Ky, B. (2021). Heart failure with targeted cancer therapies: Mechanisms and cardioprotection. Circulation Research, 128(10), 1576–1593.PubMedPubMedCentralCrossRef
7.
Makker, V., Colombo, N., Herráez, A. C., Santin, A. D., Colomba, E., Miller, D. S., Fujiwara, K., Pignata, S., Baron-Hay, S., Ray-Coquard, I., Shapira-Frommer, R., Ushijima, K., Sakata, J., Yonemori, K., Kim, Y. M., Guerra, E. M., Sanli, U. A., McCormack, M. M., Smith, A. D., … Lorusso, D. (2022). Lenvatinib plus pembrolizumab for advanced endometrial cancer. New England Journal of Medicine, 386(5), 437–448.PubMedCrossRef
8.
Schoormans, D., Vissers, P. A. J., van Herk-Sukel, M. P. P., Denollet, J., Pedersen, S. S., Dalton, S. O., Rottmann, N., & van de Poll-Franse, L. (2018). Incidence of cardiovascular disease up to 13 year after cancer diagnosis: A matched cohort study among 32 757 cancer survivors. Cancer Medicine, 7(10), 4952–4963.PubMedPubMedCentralCrossRef
9.
Wang, L., Wang, F., Chen, L., Geng, Y., Shulin, Y., & Chen, Z. (2021). Long-term cardiovascular disease mortality among 160 834 5-year survivors of adolescent and young adult cancer: An American population-based cohort study. European Heart Journal, 42(1), 101–109.PubMedCrossRef
10.
Shin, J., Ko, H., Choi, Y. H., Choi, I., & Song, Y. M. (2019). Risk of comorbid cardiovascular disease in Korean long-term cancer survivors. European Journal of Cancer Care (Engl), 28(6), e13151.CrossRef
11.
12.
Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Methods and Analytic Guidelines. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2020. Retrieved from: https://​www.​cdc.​gov/​nchs/​ahcd/​survey_​methods.​htm
13.
Cowan, A. E., Jun, S., Gahche, J. J., Tooze, J. A., Dwyer, J. T., Eicher-Miller, H. A., Bhadra, A., Guenther, P. M., Potischman, N., Dodd, K. W., & Bailey, R. L. (2018). Dietary supplement use differs by socioeconomic and health-related characteristics among US adults, NHANES 2011–2014. Nutrients, 10(8), 1114.PubMedPubMedCentralCrossRef
14.
Ogden, C. L., Carroll, M. D., Fakhouri, T. H., Hales, C. M., Fryar, C. D., Li, X., & Freedman, D. S. (2018). Prevalence of obesity among youths by household income and education level of head of household—United States 2011–2014. MMWR Morbidity and Mortality Weekly Report, 67(6), 186–189.PubMedPubMedCentralCrossRef
15.
16.
Kammerlander, A. A., Mayrhofer, T., Ferencik, M., Pagidipati, N. J., Karady, J., Ginsburg, G. S., Lu, M. T., Bittner, D. O., Puchner, S. B., Bihlmeyer, N. A., Meyersohn, N. M., Emami, H., Shah, S. H., Douglas, P. S., & Hoffmann, U. (2021). Association of metabolic phenotypes with coronary artery disease and cardiovascular events in patients with stable chest pain. Diabetes Care, 44(4), 1038–1045.PubMedPubMedCentralCrossRef
17.
van’t Klooster, C. C., Ridker, P. M., Cook, N. R., Aerts, J. G. J. V., Westerink, J., Asselbergs, F. W., van der Graaf, Y., Visseren, F. L. J., Asselbergs, F. W., Nathoe, H. M., de Borst, G. J., Bots, M. L., Geerlings, M. I., Emmelot, M. H., de Jong, P. A., Leiner, T., Lely, A. T., van der Kaaij, N. P., Kappelle, L. J., … Westerink, J. (2020). Prediction of lifetime and 10-year risk of cancer in individual patients with established cardiovascular disease. JACC: CardioOncology, 2(3), 400–410.
18.
Panagiotakos, D., Chrysohoou, C., Damigou, E., Barkas, F., Liberopoulos, E., Tsioufis, C., Sfikakis, P. P., & Pitsavos, C. (2023). Prediction of lifetime risk for cardiovascular disease, by risk factors level: The ATTICA epidemiological cohort study (2002–2022). Annals of Epidemiology, 87, 17–24.PubMedCrossRef
19.
Haider, A., Bengs, S., Luu, J., Osto, E., Siller-Matula, J. M., Muka, T., & Gebhard, C. (2020). Sex and gender in cardiovascular medicine: Presentation and outcomes of acute coronary syndrome. European Heart Journal, 41(13), 1328–1336.PubMedCrossRef
20.
Kirschbaum, T. K., Sudharsanan, N., Manne-Goehler, J., De Neve, J. W., Lemp, J. M., Theilmann, M., Marcus, M. E., Ebert, C., Chen, S., Yoosefi, M., & Sibai, A. M. (2020). The association of socioeconomic status with hypertension in 76 low-and middle-income countries. Journal of the American College of Cardiology, 80(8), 804–817.CrossRef
21.
Mefford, M. T., Li, B. H., Qian, L., Reading, S. R., Harrison, T. N., Scott, R. D., Cavendish, J. J., Jacobsen, S. J., Kanter, M. H., Woodward, M., & Reynolds, K. (2020). Sex-specific trends in acute myocardial infarction within an integrated healthcare network, 2000 through 2014. Circulation, 141(7), 509–519.PubMedCrossRef
22.
Wong, C. W., Kwok, C. S., Narain, A., Gulati, M., Mihalidou, A. S., Pensee, W., Alasnag, M., Myint, P. K., & Mamas, M. A. (2018). Marital status and risk of cardiovascular diseases: a systematic review and meta-analysis. Heart, 104(23), 1937–1948.PubMedCrossRef
23.
Dhindsa, D. S., Khambhati, J., Schultz, W. M., Tahhan, A. S., & Quyyumi, A. A. (2020). Marital status and outcomes in patients with cardiovascular disease. Trends in Cardiovascular Medicine, 30(4), 215–220.PubMedCrossRef
24.
Yang, K., Zhang, Y., Saito, E., Rahman, M. S., Gupta, P. C., Sawada, N., Tamakoshi, A., Gao, Y. T., Koh, W. P., Shu, X. O., & Tsuji, I. (2019). Association between educational level and total and cause-specific mortality: a pooled analysis of over 694 000 individuals in the Asia Cohort Consortium. British Medical Journal Open, 9(8), e026225.
25.
Hasbani, N. R., Ligthart, S., Brown, M. R., Heath, A. S., Bebo, A., Ashley, K. E., Boerwinkle, E., Morrison, A. C., Folsom, A. R., Aguilar, D., & de Vries, P. S. (2022). American heart association’s life’s simple 7: Lifestyle recommendations, polygenic risk, and lifetime risk of coronary heart disease. Circulation, 145(11), 808–818.PubMedPubMedCentralCrossRef
26.
Krishnappa, D., Wang, W., Rooney, M. R., Norby, F. L., Oldenburg, N. C., Soliman, E. Z., Alonso, A., Jin, O., Dudley, S. C., Jr., Lutsey, P. L., & Chen, L. Y. (2021). Life’s Simple 7 cardiovascular health score and premature atrial contractions: The atherosclerosis risk in communities (ARIC) study. International Journal of Cardiology, 332, 70–77.PubMedCrossRef
27.
Shen, R., Zhao, N., Wang, J., Guo, P., Shen, S., Liu, D., Liu, D., & Zou, T. (2022). Association between socioeconomic status and arteriosclerotic cardiovascular disease risk and cause-specific and all-cause mortality: Data from the 2005–2018 National Health and Nutrition Examination Survey. Frontiers in Public Health, 10, 1017271.PubMedPubMedCentralCrossRef
28.
Kaneko, H., Suzuki, Y., Ueno, K., Okada, A., Fujiu, K., Matsuoka, S., Michihata, N., Jo, T., Takeda, N., Morita, H., & Kamiya, K. (2022). Association of life’s simple 7 with incident cardiovascular disease in 53 974 patients with cancer. European Journal of Preventive Cardiology, 29(18), 2324–2332.PubMedCrossRef
29.
Johnson, C. L., Paulose-Ram, R., Ogden, C. L., Carroll, M. D., Kruszan-Moran, D., Dohrmann, S. M., & Curtin, L. R. (2013). National health and nutrition examination survey: analytic guidelines, 1999–2010. Vital Health Statistics, 2(161), 1–24.
30.
Chen, T. C., Clark, J., Riddles, M. K., Mohadjer, L. K., & Fakhouri, T. H. (2020). National health and nutrition examination survey, 2015–2018: sample design and estimation procedures. Vital Health Statistics, 2(184), 1–35.
31.
Moriarity, C., Parsons, V. L., Jonas, K., Schar, B. G., Bose, J., & Bramlett, M. D. (2022). Sample design and estimation structures for the national health interview survey, 2016–2025. Vital Health Statistics, 1(191), 1–30.
32.
Yeh, E. T., & Bickford, C. L. (2009). Cardiovascular complications of cancer therapy: Incidence, pathogenesis, diagnosis, and management. Journal of the American College of Cardiology, 53(24), 2231–2247.PubMedCrossRef
33.
Emery, J., Butow, P., Lai-Kwon, J., Nekhlyudov, L., Rynderman, M., & Jefford, M. (2022). Management of common clinical problems experienced by survivors of cancer. Lancet, 399(10334), 1537–1550.PubMedCrossRef
34.
Accordino, M. K., Neugut, A. I., & Hershman, D. L. (2014). Cardiac effects of anticancer therapy in the elderly. Journal of Clinical Oncology, 32(24), 2654–2661.PubMedPubMedCentralCrossRef
35.
Brandão, S. R., Carvalho, F., Amado, F., Ferreira, R., & Costa, V. M. (2022). Insights on the molecular targets of cardiotoxicity induced by anticancer drugs: A systematic review based on proteomic findings. Metabolism, 134, 155250.PubMedCrossRef
36.
Magdy, T., Jouni, M., Kuo, H. H., Weddle, C. J., Lyra-Leite, D., Fonoudi, H., Romero-Tejeda, M., Gharib, M., Javed, H., Fajardo, G., Ross, C. J. D., Carleton, B. C., Bernstein, D., & Burridge, P. W. (2022). Identification of drug transporter genomic variants and inhibitors that protect against doxorubicin-induced cardiotoxicity. Circulation, 145(4), 279–294.PubMedCrossRef
37.
Matthews, A. A., Hinton, S. P., Stanway, S., Lyon, A. R., Smeeth, L., Bhaskaran, K., & Lund, J. L. (2021). Risk of cardiovascular diseases among older breast cancer survivors in the United States: A matched cohort study. Journal of the National Comprehensive Cancer Network, 19(3), 275–284.PubMedCrossRef
38.
Hamood, R., Hamood, H., Merhasin, I., & Keinan-Boker, L. (2019). Risk of cardiovascular disease after radiotherapy in survivors of breast cancer: A case-cohort study. Journal of Cardiology, 73(4), 280–291.PubMedCrossRef
39.
Chang, J. S., Shin, J., Park, E. C., & Kim, Y. B. (2019). Risk of cardiac disease after adjuvant radiation therapy among breast cancer survivors. Breast, 43, 48–54.PubMedCrossRef
40.
Lee, S. F., Yip, P. L., Vellayappan, B. A., Chee, C. E., Wong, L. C., Wan, E. Y. F., Chan, E. W. Y., Lee, C. F., Lee, F. A. S., & Luque-Fernandez, M. A. (2022). Incident cardiovascular diseases among survivors of high-risk stage II-III colorectal cancer: A cluster-wide cohort study. Journal of the National Comprehensive Cancer Network, 20(10), 1125–1133.PubMedCrossRef
41.
Kenzik, K. M., Balentine, C., Richman, J., Kilgore, M., Bhatia, S., & Williams, G. R. (2018). New-onset cardiovascular morbidity in older adults with stage I to III colorectal cancer. Journal of Clinical Oncology, 36(6), 609–616.PubMedCrossRef
42.
Wang, C. Y., Zoungas, S., Voskoboynik, M., & Mar, V. (2022). Cardiovascular disease and malignant melanoma. Melanoma Research, 32(3), 135–141.PubMedCrossRef
43.
Strongman, H., Gadd, S., Matthews, A., Mansfield, K. E., Stanway, S., Lyon, A. R., dos-Santos-Silva, I., Smeeth, L., & Bhaskaran, K. (2019). Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases. Lancet, 394(10203), 1041–1054.PubMedPubMedCentralCrossRef
44.
Armenian, S. H., Lanfang, X., Ky, B., Sun, C., Farol, L. T., Pal, S. K., Douglas, P. S., Bhatia, S., & Chao, C. (2016). Cardiovascular disease among survivors of adult-onset cancer: A community-based retrospective cohort study. Journal of Clinical Oncology, 34(10), 1122–1130.PubMedPubMedCentralCrossRef
45.
46.
de Vries, S., Haaksma, M. L., Jóźwiak, K., Schaapveld, M., Hodgson, D. C., Lugtenburg, P. J., Krol, A. D. G., Petersen, E. J., Johan, D., van Spronsen, S., Ahmed, M. H., Aleman, B. M. P., & van Leeuwen, F. E. (2023). Development and validation of risk prediction models for coronary heart disease and heart failure after treatment for Hodgkin lymphoma. Journal of Clinical Oncology, 41(1), 86–95.PubMedCrossRef
47.
Yoon, D. W., Shin, D. W., Cho, J. H., Yang, J. H., Jeong, S. M., Han, K., & Park, S. H. (2019). Increased risk of coronary heart disease and stroke in lung cancer survivors: A Korean nationwide study of 20,458 patients. Lung Cancer, 136, 115–121.PubMedCrossRef
48.
Florido, R., Daya, N. R., Ndumele, C. E., Koton, S., Russell, S. D., Prizment, A., Blumenthal, R. S., Matsushita, K., Mok, Y., Felix, A. S., Coresh, J., Joshu, C. E., Platz, E. A., & Selvin, E. (2022). Cardiovascular disease risk among cancer survivors: The atherosclerosis risk in communities (ARIC) study. Journal of the American College of Cardiology, 80(1), 22–32.PubMedPubMedCentralCrossRef
49.
Kim, K. J., Song, J. E., Kim, J. Y., Bae, J. H., Kim, N. H., Yoo, H. J., Kim, H. Y., Seo, J. A., Kim, N. H., Lee, J., Choi, K. M., Baik, S. H., & Kim, S. G. (2020). Effects of radioactive iodine treatment on cardiovascular disease in thyroid cancer patients: A nationwide cohort study. Annals of Translational Medicine, 8(19), 1235.PubMedPubMedCentralCrossRef
50.
Lega, I. C., & Lipscombe, L. L. (2020). Review: Diabetes, obesity, and cancer-pathophysiology and clinical implications. Endocrine Reviews, 41(1), bnz014.PubMedCrossRef
51.
Michel, L., Schadendorf, D., & Rassaf, T. (2020). Oncocardiology: New challenges, new opportunities. Onkokardiologie: Neue Herausforderungen, neue Möglichkeiten. Herz, 45(7), 619–625.PubMedPubMedCentralCrossRef
52.
Khan, S. S., & Greenland, P. (2020). Comprehensive cardiovascular health promotion for successful prevention of cardiovascular disease. JAMA, 324(20), 2036–2037.PubMedCrossRef
53.
Yang, Q., Cogswell, M. E., Dana Flanders, W., Hong, Y., Zhang, Z., Loustalot, F., Gillespie, C., Merritt, R., & Frank, BHu. (2012). Trends in cardiovascular health metrics and associations with all-cause and CVD mortality among US adults. JAMA, 307(12), 1273–1283.PubMedPubMedCentralCrossRef
54.
Gaye, B. \, Canonico, M., Perier, M. C., Samieri, C., Berr, C., Dartigues, J.-F., Tzourio, C., Elbaz, A., & Empana, J. P. (2017). Ideal cardiovascular health, mortality, and vascular events in elderly subjects: The three-city study. Journal of the American College of Cardiology, 69(25), 3015–3026.PubMedCrossRef
55.
Perak, A. M., Ning, H., Khan, S. S., Bundy, J. D., Allen, N. B., Lewis, C. E., Jacobs, D. R., Van Horn, L. V., & Lloyd-Jones, D. M. (2020). Associations of late adolescent or young adult cardiovascular health with premature cardiovascular disease and mortality. Journal of the American College of Cardiology, 76(23), 2695–2707.PubMedPubMedCentralCrossRef
56.
Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Donald Lloyd-Jones, J., McEvoy, W., Michos, E. D., Miedema, M. D., Muñoz, D., Smith, S. C., Virani, S. S., Williams, K. A., Yeboah, J., & Ziaeian, B. (2019). ACC/AHA guideline on the primary prevention of cardiovascular disease: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Journal of the American College of Cardiology., 74(10), 1376–1414.PubMedPubMedCentralCrossRef
57.
Walker, W. H., II., Meléndez-Fernández, O. H., Pascoe, J. L., Zhang, N., & DeVries, A. C. (2020). Social enrichment attenuates chemotherapy induced pro-inflammatory cytokine production and affective behavior via oxytocin signaling. Brain, Behavior, and Immunity, 89, 451–464.PubMedPubMedCentralCrossRef
Metadata
Title
Association Between Cancer and Cardiovascular Toxicity: A Nationwide Cross-Sectional Study on NHANES 1999–2018
Authors
Ruihuan Shen
Tong Zou
Publication date
11-03-2024
Publisher
Springer US
Keyword
Nutrition
Published in
Cardiovascular Toxicology / Issue 4/2024
Print ISSN: 1530-7905
Electronic ISSN: 1559-0259
DOI
https://doi.org/10.1007/s12012-024-09845-6

Other articles of this Issue 4/2024

Cardiovascular Toxicology 4/2024 Go to the issue

Research

Subacute Exposure to Gaseous Pollutants from Diesel Engine Exhaust Attenuates Capsaicin-Induced Cardio-Pulmonary Reflex Responses Involving Oxidant Stress Mechanisms in Adult Wistar Rats

Research

Arterial Stiffness May Predict Subsequent Cancer Therapy-Related Cardiac Dysfunction in Breast Cancer Patients

OriginalPaper

The Association of Iron Intake and Hypertension, Does Iron Intake Decrease Blood Pressure?

Research

Development and Validation of Machine Learning Algorithms to Predict 1-Year Ischemic Stroke and Bleeding Events in Patients with Atrial Fibrillation and Cancer

OriginalPaper

Correlation Between Blood Cadmium Levels and Platelet Characteristics, As Well As Their Impact on Susceptibility to Coronary Heart Disease: Findings from NHANES 2005–2018 Data

OriginalPaper

BMSCs-derived Exosome CISH Alleviates Myocardial Infarction by Inactivating the NF-κB Pathway to Stimulate Macrophage M2 Polarization